Target Name: BDKRB1
NCBI ID: G623
Review Report on BDKRB1 Target / Biomarker Content of Review Report on BDKRB1 Target / Biomarker
BDKRB1
Other Name(s): BDKRB1 variant 1 | B1 bradykinin receptor | BRADYB1 | bradykinin receptor B1 | BKR1 | bradykinin B1 receptor | bradykinin receptor 1 | B1R | B1BKR | BKRB1_HUMAN | Bradykinin receptor B1, transcript variant 1 | BKB1R | BK-1 receptor

Study of BDKRB1 in Bcr/Abl Signaling Pathway

BDKRB1 (Bcr/Abl-associated kinase 1) is a protein that is expressed in various tissues, including leukemia, and it is known to play a role in the proliferation and survival of cancer cells. The Bcr/Abl-associated kinase (BAK) signaling pathway is a well-established mechanism that is involved in the regulation of cell proliferation, differentiation, and survival. The BAK signaling pathway is a critical pathway in the development and progression of many diseases, including cancer. Therefore, the study of BDKRB1 and its role in this pathway is of great interest.

BDKRB1 is a 21-kDa protein that is expressed in various tissues, including leukemia, and it is a key component of the BAK signaling pathway. The BAK signaling pathway is a complex signaling pathway that is involved in the regulation of cell proliferation, differentiation, and survival. The BAK signaling pathway is activated by various signals, including tyrosine, which is produced by various signaling pathways, including the Bcr/Abl signaling pathway.

The Bcr/Abl signaling pathway is a well-established mechanism that is involved in the regulation of cell proliferation, differentiation, and survival. The Bcr/Abl signaling pathway is activated by various signals, including tyrosine, which is produced by various signaling pathways, including the TOR signaling pathway. The TOR signaling pathway is a critical pathway that is involved in the regulation of cell growth, metabolism, and stress responses. Therefore, the study of BDKRB1 and its role in the Bcr/Abl signaling pathway is of great interest.

BDKRB1 is involved in the regulation of various cellular processes, including cell growth, differentiation, and survival. It is known to play a role in the regulation of cell proliferation by promoting the growth of cancer cells and inhibiting the growth of normal cells. BDKRB1 is also involved in the regulation of cell differentiation by promoting the transformation of cancer cells and inhibiting the transformation of normal cells.

BDKRB1 is also involved in the regulation of cell survival by promoting the survival of cancer cells and inhibiting the survival of normal cells. This is done through various mechanisms, including the inhibition of apoptosis, which is the process of cell death, and the inhibition of autophagy, which is the process of cell death by degradation.

In conclusion, BDKRB1 is a protein that is involved in the regulation of various cellular processes, including cell growth, differentiation, and survival. The BAK signaling pathway is a critical pathway that is involved in the regulation of cell proliferation, differentiation, and survival. The study of BDKRB1 and its role in the Bcr/Abl signaling pathway is of great interest. Further research is needed to fully understand the role of BDKRB1 in the regulation of cell proliferation, differentiation, and survival.

Protein Name: Bradykinin Receptor B1

Functions: This is a receptor for bradykinin. Could be a factor in chronic pain and inflammation

The "BDKRB1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BDKRB1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

BDKRB2 | BDNF | BDNF-AS | BDP1 | BEAN1 | BEAN1-AS1 | BECN1 | BECN2 | BEGAIN | BEND2 | BEND3 | BEND3P3 | BEND4 | BEND5 | BEND6 | BEND7 | BEST1 | BEST2 | BEST3 | BEST4 | BET1 | BET1L | beta-Adrenoceptor | beta-Crystallin | beta-Hexosaminidase Complex | beta-Secretase | BEX1 | BEX2 | BEX3 | BEX4 | BEX5 | BFAR | BFSP1 | BFSP2 | BFSP2-AS1 | BGLAP | BGLT3 | BGN | BHC complex | BHLHA15 | BHLHA9 | BHLHE22 | BHLHE22-AS1 | BHLHE23 | BHLHE40 | BHLHE40-AS1 | BHLHE41 | BHMT | BHMT2 | BICC1 | BICD1 | BICD2 | BICDL1 | BICDL2 | BICRA | BICRAL | BID | BIK | BIN1 | BIN2 | BIN3 | BIN3-IT1 | Biogenesis of lysosome-related organelles complex-1 | BIRC2 | BIRC3 | BIRC5 | BIRC6 | BIRC7 | BIRC8 | BISPR | BIVM | BIVM-ERCC5 | BLACAT1 | BLACE | BLCAP | BLID | BLK | BLM | BLMH | BLNK | BLOC-1 (biogenesis of lysosome-related organelles complex 1) | BLOC1S1 | BLOC1S1-RDH5 | BLOC1S2 | BLOC1S3 | BLOC1S4 | BLOC1S5 | BLOC1S5-TXNDC5 | BLOC1S6 | BLTP1 | BLTP2 | BLTP3A | BLTP3B | BLVRA | BLVRB | BLZF1 | BMAL1 | BMAL2 | BMAL2-AS1 | BMERB1